Recombinant Human Melanoma antigen recognized by T-cells 1(MLANA)

Specification
Organism Homo sapiens (Human)
Expression Host E.coli
Tag Info N-terminal 6xHis-B2M-tagged
Purity Greater than 85% by SDS-PAGE
Uniprot ID Q16655
Gene Names MLANA
Alternative Names Antigen LB39-AAAntigen SK29-AAProtein Melan-A
Expression Region Full Length(1-118aa )
Molecular Weight 27.2 kDa
Protein Sequence MPREDAHFIYGYPKKGHGHSYTTAEEAAGIGILTVILGVLLLIGCWYCRRRNGYRALMDKSLHVGTQCALTRRCPQEGFDHRDSKVSLQEKNCEPVVPNAPPAYEKLSAEQSPPPYSP
Form Liquid or Lyophilization
Buffer The default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol if the delivery form is liquid. The lyophilization buffer is Tris/PBS-based buffer, 6% Trehalose, pH 8.0 if the delivery form is lyophilized powder. Please contact us if you have any special requirment.
Reconstitution Please reconstitute protein in deionized sterile water and we recommend that briefly centrifuge thevial prior to opening the vial .We recommend aliquot for long-term storage at -20℃/-80℃.
Background
Relevance Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes.
Involvement in Disease
Subcellular Location Endoplasmic reticulum membrane, Single-pass type III membrane protein, Golgi apparatus, Golgi apparatus, trans-Golgi network membrane, Melanosome
Protein Families
Tissue Specificity MLANA
QC Data
Note Please contact us for QC Data
Product Image (Reference Only) Product via image
$202.00
In stock
SKU
EB-PE8HU622093

Recombinant Human Melanoma antigen recognized by T-cells 1(MLANA)

Question / Bulk Inquiry
Please leave us a message if you have any questions or have bulk order inquiry, we will get back to you in 24 hours.
Please type the letters and numbers below

 

Reviews

Write Your Own Review
You're reviewing:Recombinant Human Melanoma antigen recognized by T-cells 1(MLANA)
Copyright © 2021-present Echo Biosystems. All rights reserved.